PHM — Pharma Mar SA Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual income statement for Pharma Mar SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	230	196	158	175	221
Cost of Revenue
Gross Profit	213	183	149	167	209
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	137	152	162	168	161
Operating Profit	92.4	44.1	-3.83	6.47	60.7
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	95.1	43.8	-3.62	12	59.7
Provision for Income Taxes
Net Income After Taxes	92.9	49.4	1.14	26.1	75
Net Income Before Extraordinary Items
Net Income	92.9	49.4	1.14	26.1	75
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	92.9	49.4	1.14	26.1	75
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	5.12	2.8	0.067	1.47	4.27
Dividends per Share